Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine ; volume:10 ; number:1 ; day:5 ; month:12 ; year:2019 ; pages:46-58 ; date:3.2020
Journal of epidemiology and global health ; 10, Heft 1 (5.12.2019), 46-58, 3.2020
- Creator
-
Wilder-Smith, Annika B.
Qureshi, Kaveri
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.2991/jegh.k.191117.001
- URN
-
urn:nbn:de:101:1-2024032209414248262330
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wilder-Smith, Annika B.
- Qureshi, Kaveri
- SpringerLink (Online service)
Other Objects (12)
Measles Resurgence in Europe: Migrants and Travellers are not the Main Drivers
COVID’s collateral damage: likelihood of measles resurgence in the United States
Measles Resurgence Associated with Continued Circulation of Genotype H1 Viruses in China, 2005
Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018
Necrotizing fasciitis following measles vaccine administration: a case report
Factors associated with measles resurgence in the United States in the post-elimination era
Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination
Measles : pathogenesis and control
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Local public health response to vaccine-associated measles: case report
Measles Resurgence in Europe: Migrants and Travellers are not the Main Drivers
COVID’s collateral damage: likelihood of measles resurgence in the United States
Measles Resurgence Associated with Continued Circulation of Genotype H1 Viruses in China, 2005
Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018
Necrotizing fasciitis following measles vaccine administration: a case report
Factors associated with measles resurgence in the United States in the post-elimination era
Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination
Measles : pathogenesis and control
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Local public health response to vaccine-associated measles: case report
Measles Resurgence in Europe: Migrants and Travellers are not the Main Drivers
COVID’s collateral damage: likelihood of measles resurgence in the United States
Measles Resurgence Associated with Continued Circulation of Genotype H1 Viruses in China, 2005
Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018
Necrotizing fasciitis following measles vaccine administration: a case report
Factors associated with measles resurgence in the United States in the post-elimination era
Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination
Measles : pathogenesis and control
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles